National Asset Management, Inc. Catalyst Biosciences, Inc. Transaction History

National Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$7.67 - $9.96 $268,450 - $348,600	-35,000 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$6.59 - $11.28 $65,900 - $112,800	10,000 Added 40.0%	35,000 $277,000
Q2 2018 Oct 05, 2018	SELL	$9.11 - $28.88 $154,870 - $490,960	-17,000 Reduced 40.48%	25,000 $292,000
Q1 2018 May 15, 2018	SELL	$14.18 - $35.6 $290,690 - $729,800	-20,500 Reduced 32.8%	42,000 $1.08 Million
Q4 2017 Feb 15, 2018	BUY	$4.52 - $13.69 $282,500 - $855,625	62,500	62,500 $853,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.